About 900 reports

  • HIGHLIGHTS

Ado-trastuzumab emtansine (Kadcyla, ), an antibody that targets HER##, attaches itself to a chemo drug called Myotonic dystrophy type ## (DM##).

  • Monoclonal Antibody
  • Amgen Inc.
  • Biocon Limited
  • Mylan Inc.
  • Roche Group
  • VERSATILITY OF PIPELINE PRODUCTS ACROSS THERAPY AREAS, INDICATIONS AND TARGETS
  • MARKETED MAB PRODUCTS, OPDIVO

Monoclonal Antibodies - Global Trends in the Competitive, Technological and R&D Landscape Summary Antibodies, otherwise known as immunoglobulins (Ig), are large, Y-shaped glycoproteins produced by immune cells in response to pathogens such as bacteria and viruses. They consist of two large heavy polypeptide chains and...

  • Monoclonal Antibody
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Genentech, Inc.
  • Johnson & Johnson
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND
  • IV. MONOCLONAL ANTIBODY PRODUCTION AND

China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...

  • Monoclonal Antibody
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Beijing Tiantan Biological Products Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.
  • Demand of Monoclonal Antibody by Region
  • Monoclonal Antibody Imports

This study focuses on China’s Monoclonal Antibody industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s...

  • Monoclonal Antibody
  • China
  • Demand
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

GLOBAL BIOSIMILAR MONOCLONAL ANTIBODIES FORECAST 2018-2028 ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Market Size
  • ANTI-CANCER MABS ACT AGAINST MALIGNANT CELLS THROUGH THE MECHANISMS MENTIONED IN THE EXHIBIT BELOW.
  • EXECUTIVE SUMMARY

About Monoclonal Antibodies Antibodies are the proteins produced by B-cells (in the bone marrow) in the immune system. These proteins attach themselves to antigens, which act as markers, and are then destroyed by phagocytes. B-cells produce different antibodies, which attach themselves to different sites of an antigen. mAbs are monospecific,...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Amgen Inc.

Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts Executive Summary Chapter ## – Introduction Chapter ## – Trends in Cancer monoclonal antibody dealmaking ##. ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Demand
  • Monoclonal Antibody Sales Volume
  • Monoclonal Antibody Companies in China

This study focuses on China’s Monoclonal Antibody industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...

  • Monoclonal Antibody
  • China
  • Beijing Biotech Pharmaceutical Co., Ltd.
  • Roche Group
  • Shanghai CP Guojian Pharmaceutical Co., Ltd.

Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Monoclonal Antibody
  • Pharmaceutical
  • APAC
  • World
  • Market Size

The 2019-2024 World Outlook for Biosimilar Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Breast Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand

The 2019-2024 World Outlook for Rheumatoid Arthritis (RA) Monoclonal Antibodies (mAb) ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • World
  • Demand
  • SCOPE OF THE REPORT
  • KEY NEWS

ADCETRIS is a chimeric monoclonal immunoglobulin (Ig)G## antibody, which acts against CD## expressed in HL and systemic anaplastic large cell lymphoma.

  • Monoclonal Antibody
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

The Development of Therapeutic Monoclonal Antibody Products CHAPTER ##: The Therapeutic Monoclonal Antibody Market ## CHAPTER ##: Overview of Chemistry, Manufacturing, and Control Activities for Monoclonal Antibody Product Developm

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • Demand

Each monoclonal antibody recognizes one particular protein.

  • Monoclonal Antibody
  • Therapy
  • APAC
  • World
  • Market Size
  • MONOCLONAL ANTIBODIES (MABS)
  • Global Monoclonal Antibodies Market, 2017, By Source

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes.Biologics products include a wide range of recombinant therapeutic proteins, vaccines, and monoclonal antibodies. These products are isolated from natural sources such as human, animal, and...

  • Monoclonal Antibody
  • World
  • Market Size
  • AbbVie Inc.
  • Pfizer Inc.
  • 6.1 MONOCLONAL ANTIBODIES
  • Middle East & African Biosimilar Market, Monoclonal Antibodies,

The global biosimilar market was estimated to be valued at USD 3,474.01 million in 2017, and is expected to register a CAGR of 43.85% during the forecast period of 2018-2023. North America accounted for the largest share of approximately 30% of the global market, in 2017, while Asia-Pacific region is anticipated to register the highest CAGR...

  • Monoclonal Antibody
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.

Monoclonal Antibodies (mAbs) Market Analysis By Source (Chimeric, Murine, Humanized, Human), By Type of Production, By Indication (Cancer, Autoimmune, Inflammatory, Infectious, Microbial, Viral Diseases), By End-use And Segment Forecasts, 2013 - 2024 Table of Contents Chapter

  • Monoclonal Antibody
  • United States
  • Demand
  • Market Size
  • Supply

Biosimilar Monoclonal Antibodies Market Forecast 2016-2026: Biosimilar Versions of Infliximab, Rituximab, Trastuzumab, Adalimumab, Bevacizumab and Abciximab ##.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Market Size
  • 7.1.1.2 ANTI-INFLAMMATORY MONOCLONAL ANTIBODIES
  • 7.1.1.3 OTHER MONOCLONAL ANTIBODIES

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements. Increasing Acceptance for Biopharmaceuticals and Significant Market Demand Opportunities...

  • Biopharmaceutical
  • Biotechnology
  • Monoclonal Antibody
  • World
  • Market Size

& nbsp; Chapter ##: Introduction Study Goals and Objectives Monoclonal antibodies are a type of bioengineered protein drugs.

  • Monoclonal Antibody
  • Therapy
  • World
  • Market Shares
  • Monoclonal Antibody Sales Volume (million Yuan)
  • Monoclonal Antibody Sales Volume (million Yuan)

This study focuses on China’s Kidney Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Monoclonal Antibody
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Monoclonal Antibody Sales Volume (million Yuan)
  • Monoclonal Antibody Sales Volume (million Yuan)

China’s demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports,...

  • Monoclonal Antibody
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Source: GBI Research Proprietary Pipeline Product Database, GBI Research Analysis Abbreviations: mAb: monoclonal Antibody
  • Prostaglandinsand receptors

Global Dermatology Drugs Market to 2023 - Growth Driven by Increased Uptake of Interleukin Receptor Inhibitors for Psoriasis and Atopic Dermatitis Summary Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist,...

  • Monoclonal Antibody
  • World
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Source: GBI Research, company reported data, analyst consensus Abbreviations: mAb: monoclonal antibody
  • Source: GBI Research, company reported data, analyst consensus Abbreviations: mAb: monoclonal antibody; TNF: tumor necrosis factor

Global Gastrointestinal Drug Market to 2022 - Pipeline Characterized by Emerging Biologic Therapies, While TNF Inhibitors and PPIs Continue to Dominate Therapy Landscape Summary Gastrointestinal disorders are common, and a number of them have a large patient population. Across the seven major markets (the US, the UK, France,...

  • Monoclonal Antibody
  • World
  • Market Size
  • AstraZeneca PLC
  • Takeda Pharmaceutical Company Limited
  • 4.4 MONOCLONAL ANTIBODY (MAB) BIOSIMILARS MARKET AND FORECAST
  • The major Amgen pipeline biosimilars in various stages of development are:

The biosimilars are poised to capture an unprecedented position in the biopharmaceutical industry driven by an increased extent of adoption and growing investment and deal making activity globally. The global biosimilars market is predicted to cross US$ 25 Billion mark by 2020. With the continuous increasing demand for biologics,...

  • Monoclonal Antibody
  • World
  • Market Size
  • Amgen Inc.
  • Biocon Limited

Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 ##.

  • Breast Cancer
  • Monoclonal Antibody
  • Therapy
  • World
  • Forecast